Barbara Polityńska

1 ta ish

University of Cambridge

1. Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners

   Marek Z. Wojtukiewicz, Magdalena M. Rek, Kamil Karpowicz +7

   Sharh maqolaOAOchiq kirish20213 iqtibos

   ABIABI:AkademIndex/2026.other.236588